Oya Güven
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oya Güven has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Merve Demireller
Department of Emergency Medicine, Kırklareli University School of Medicine, Kırklareli, Türkiye
8 shared publications - Lale Tuna
Kırklareli Eğitim ve Araştırma Hastanesi
7 shared publications - Bedriye Feyza Kurt
KIRKLARELİ EĞİTİM VE ARAŞTIRMA HASTANESİ
6 shared publications - Tugce Uskur
Department of Medical Pharmacology, Faculty of Medicine, Kırklareli University, Kırklareli, Türkiye
5 shared publications - Abdulrahman Naser
Department of Cardiology, Kırklareli Training and Research Hospital, Kırklareli, Türkiye
4 shared publications - Samet Sayılan
Kırklareli University Medical School, Turquia
4 shared publications
Latest Publications
- 28 February 2026
- Published by Ağrı İbrahim Çeçen University Faculty of Medicine in Ağrı Tıp Fakültesi Dergisi
- Vol. 4 (1) , 15-22
The role of consistency and experience among physicians from different specialties in the interpretation of brain tomography
Aim: This study examined the consistency rate among physicians and the factors affecting it when interpreting brain computed tomography (CT) scans of emergency department (ED) patients. Materials and Methods: This study retrospectively examined the records of patients who presented to the ED. For one month, all brain tomography requested from the emergency department due to cerebrovascular disease (stroke/CVD) or trauma were reviewed by the general practitioner, emergency medicine specialist, neurologist, and radiologists. Cohen’s Kappa statistics were used to measure consistency. The near the Kappa result is to 1, the higher the perceived level of consistency in the results.Results: The study analyzed brain CT interpretations of 291 patients. Radiologists detected bleeding in 12 patients (4.1%). In patients with bleeding, in the group with both trauma and CVD, a significant (p < 0.05) consistency was observed between all clinicians and radiologists. When consistency in patient outcomes according to the hospital was examined, a significant (p < 0.05) consistency was observed between the emergency medicine specialist, neurologist, and radiologists in the discharged and hospitalized groups. There was no consistency between the general practitioner and the radiologists in both groups.Conclusion: In this study, the general practitioner's consistency with the radiologists was low, while the consistency of the other clinicians was high. This result suggests that collaborating with the emergency medicine specialist and neurologist can reduce the misinterpretation rate.
- 28 February 2026
- Published by Ağrı İbrahim Çeçen University Faculty of Medicine in Ağrı Tıp Fakültesi Dergisi
- Vol. 4 (1) , 15-22
The role of consistency and experience among physicians from different specialties in the interpretation of brain tomography
Aim: This study examined the consistency rate among physicians and the factors affecting it when interpreting brain computed tomography (CT) scans of emergency department (ED) patients. Materials and Methods: This study retrospectively examined the records of patients who presented to the ED. For one month, all brain tomography requested from the emergency department due to cerebrovascular disease (stroke/CVD) or trauma were reviewed by the general practitioner, emergency medicine specialist, neurologist, and radiologists. Cohen’s Kappa statistics were used to measure consistency. The near the Kappa result is to 1, the higher the perceived level of consistency in the results.Results: The study analyzed brain CT interpretations of 291 patients. Radiologists detected bleeding in 12 patients (4.1%). In patients with bleeding, in the group with both trauma and CVD, a significant (p < 0.05) consistency was observed between all clinicians and radiologists. When consistency in patient outcomes according to the hospital was examined, a significant (p < 0.05) consistency was observed between the emergency medicine specialist, neurologist, and radiologists in the discharged and hospitalized groups. There was no consistency between the general practitioner and the radiologists in both groups.Conclusion: In this study, the general practitioner's consistency with the radiologists was low, while the consistency of the other clinicians was high. This result suggests that collaborating with the emergency medicine specialist and neurologist can reduce the misinterpretation rate.
- 31 December 2025
- Published by Acil Tip Uzmanlari Dernegi in Eurasian Journal of Critical Care
- Vol. 7 (3) , 51-53
Bradykinin-Mediated Angioedema Associated with ACE Inhibitor, Managed with C1 Esterase Inhibitor
Introduction: Bradykinin-mediated angioedema is a rare clinical condition that can present diagnostic challenges, particularly when it occurs independently of C1 esterase inhibitor activity. One of the most common triggers is angiotensin-converting enzyme (ACE) inhibitors, which can lead to edema by preventing the breakdown of bradykinin. Case Presentation: A 70-year-old male patient, using an ACE inhibitor for hypertension, presented to the emergency department with tongue swelling after receiving cisplatin-docetaxel-5 fluorouracil treatment for laryngeal cancer. His symptoms did not improve with anti-allergic treatment, but showed rapid resolution following administration of C1 esterase inhibitor. Discussion: This case presents a bradykinin-mediated angioedema episode associated with ACE inhibitor use, which responded to C1 esterase inhibitor treatment. Clinicians should consider C1 esterase inhibitor therapy in cases unresponsive to standard allergy treatments.
- 31 December 2025
- Published by Acil Tip Uzmanlari Dernegi in Eurasian Journal of Critical Care
- Vol. 7 (3) , 51-53
Bradykinin-Mediated Angioedema Associated with ACE Inhibitor, Managed with C1 Esterase Inhibitor
Introduction: Bradykinin-mediated angioedema is a rare clinical condition that can present diagnostic challenges, particularly when it occurs independently of C1 esterase inhibitor activity. One of the most common triggers is angiotensin-converting enzyme (ACE) inhibitors, which can lead to edema by preventing the breakdown of bradykinin. Case Presentation: A 70-year-old male patient, using an ACE inhibitor for hypertension, presented to the emergency department with tongue swelling after receiving cisplatin-docetaxel-5 fluorouracil treatment for laryngeal cancer. His symptoms did not improve with anti-allergic treatment, but showed rapid resolution following administration of C1 esterase inhibitor. Discussion: This case presents a bradykinin-mediated angioedema episode associated with ACE inhibitor use, which responded to C1 esterase inhibitor treatment. Clinicians should consider C1 esterase inhibitor therapy in cases unresponsive to standard allergy treatments.
- 27 September 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 248, 108383
EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial
- 27 September 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 248, 108383
EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial
- Open Access
- 16 September 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (5) , 884-888
Therapeutic drug monitoring of carbamazepine and valproic acid: interindividual variability in epilepsy patients
Aims: Epilepsy is a chronic neurological disorder affecting 1-3% of the global population, characterized by recurrent seizures. Monitoring blood levels of valproic acid and carbamazepine, two commonly used antiepileptic drugs, is essential for effective seizure control. This study aims to analyze the serum concentrations, demographic characteristics and concomitant drug use of patients treated with valproic acid or carbamazepine. Methods: This retrospective study was conducted at Kırklareli Training and Research Hospital, analyzing the medical records of epilepsy patients treated with valproic acid or carbamazepine. Medical records of 440 epilepsy patients were retrospectively analyzed. Demographic data, concurrent medication use and blood drug levels were recorded, and rates of achieving therapeutic levels were compared. Results: Of the 440 patients, 378 were treated with valproic acid, and 62 with carbamazepine. In the valproic acid group, 62.2% reached therapeutic levels, with an average concentration of 68.15 µg/ml. In the carbamazepine group, only 27.4% reached therapeutic levels, with an average of 10.07 µg/ml. A statistically significant difference was found between the two groups. A significant association was found between drug interaction counts and non-therapeutic levels in the carbamazepine group (p
- 16 September 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (5) , 884-888
Open AccessTherapeutic drug monitoring of carbamazepine and valproic acid: interindividual variability in epilepsy patients
Aims: Epilepsy is a chronic neurological disorder affecting 1-3% of the global population, characterized by recurrent seizures. Monitoring blood levels of valproic acid and carbamazepine, two commonly used antiepileptic drugs, is essential for effective seizure control. This study aims to analyze the serum concentrations, demographic characteristics and concomitant drug use of patients treated with valproic acid or carbamazepine. Methods: This retrospective study was conducted at Kırklareli Training and Research Hospital, analyzing the medical records of epilepsy patients treated with valproic acid or carbamazepine. Medical records of 440 epilepsy patients were retrospectively analyzed. Demographic data, concurrent medication use and blood drug levels were recorded, and rates of achieving therapeutic levels were compared. Results: Of the 440 patients, 378 were treated with valproic acid, and 62 with carbamazepine. In the valproic acid group, 62.2% reached therapeutic levels, with an average concentration of 68.15 µg/ml. In the carbamazepine group, only 27.4% reached therapeutic levels, with an average of 10.07 µg/ml. A statistically significant difference was found between the two groups. A significant association was found between drug interaction counts and non-therapeutic levels in the carbamazepine group (p
- Open Access
- 6 September 2025
- Published by Atatürk University, Medical Faculty in Trends in Surgical Sciences
- Vol. 4 (2) , 65-72
The Impact of Weather and Air Conditions on Pediatric Emergency Department Visits in 20192022: A Single-Center Study
Objective: This study aimed to explore the impact of environmental factors, specifically adverse weather conditions, on the rate of pediatric emergency department visits. Methods: A retrospective analysis was performed at a tertiary care hospital specializing in pediatric and emergency medicine. Data on environmental factors, including particulate matter (PM10) and nitrogen oxide (NOX) levels, temperature, wind speed, and precipitation, were collected from official Turkish sources and correlated with pediatric emergency department admissions over a year. Admissions were categorized seasonally, and analyzed variables included patient demographics, visit details, diagnosis, and outcomes, utilizing ICD-10 codes for a broad range of conditions. Results: A retrospective study from 2019 to 2022 investigated 126,364 pediatric patients aged < 15 years. Seasonal variation was noted, with the highest number of admissions in the fall of 2022. Admissions significantly decreased during periods of water and air pollution, with the most substantial decline seen during the pandemic year of 2021. During the post-pandemic period, there was a sharp increase in the number of visits. Upper respiratory tract infections (URTIs) constitute 47% of all cases and are the leading cause of emergency department visits. The majority of patients (99%) walked, whereas only 1% arrived by ambulance. (0.2%) required referral to higher-level care, and 3% of emergency visits resulted in hospital admissions, of which 5% required intensive care. The frequency of visits was correlated with environmental factors, with fewer visits occurring during adverse weather conditions (P<.001). URTIs remained the predominant diagnosis, even during extreme weather or pollution events, suggesting that such environmental factors did not diminish the urgency of these conditions. Conclusion: This study found that environmental factors influence child emergency room visits, particularly during summer when children engage in more outdoor activities due to warmer weather. Based on the results obtained, health systems are able to allocate resources and formulate response strategies that enhance the provision of care for children, thereby increasing the resilience of the emergency health services infrastructure.
- 6 September 2025
- Published by Atatürk University, Medical Faculty in Trends in Surgical Sciences
- Vol. 4 (2) , 65-72
Open AccessThe Impact of Weather and Air Conditions on Pediatric Emergency Department Visits in 20192022: A Single-Center Study
Objective: This study aimed to explore the impact of environmental factors, specifically adverse weather conditions, on the rate of pediatric emergency department visits. Methods: A retrospective analysis was performed at a tertiary care hospital specializing in pediatric and emergency medicine. Data on environmental factors, including particulate matter (PM10) and nitrogen oxide (NOX) levels, temperature, wind speed, and precipitation, were collected from official Turkish sources and correlated with pediatric emergency department admissions over a year. Admissions were categorized seasonally, and analyzed variables included patient demographics, visit details, diagnosis, and outcomes, utilizing ICD-10 codes for a broad range of conditions. Results: A retrospective study from 2019 to 2022 investigated 126,364 pediatric patients aged < 15 years. Seasonal variation was noted, with the highest number of admissions in the fall of 2022. Admissions significantly decreased during periods of water and air pollution, with the most substantial decline seen during the pandemic year of 2021. During the post-pandemic period, there was a sharp increase in the number of visits. Upper respiratory tract infections (URTIs) constitute 47% of all cases and are the leading cause of emergency department visits. The majority of patients (99%) walked, whereas only 1% arrived by ambulance. (0.2%) required referral to higher-level care, and 3% of emergency visits resulted in hospital admissions, of which 5% required intensive care. The frequency of visits was correlated with environmental factors, with fewer visits occurring during adverse weather conditions (P<.001). URTIs remained the predominant diagnosis, even during extreme weather or pollution events, suggesting that such environmental factors did not diminish the urgency of these conditions. Conclusion: This study found that environmental factors influence child emergency room visits, particularly during summer when children engage in more outdoor activities due to warmer weather. Based on the results obtained, health systems are able to allocate resources and formulate response strategies that enhance the provision of care for children, thereby increasing the resilience of the emergency health services infrastructure.
- 1 September 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (9) , 678-682
Clinical effects of potential drug-drug interactions in hemorrhagic stroke patients admitted to the emergency department
Aim Hemorrhagic stroke is a medical condition characterized by non-traumatic intracranial bleeding, leading to high mortality and morbidity, and is frequently diagnosed in emergency departments. Its prevalence varies between countries, highlighting the importance of investigating modifiable risk factors. Drug-drug interactions (DDIs) may contribute to its development. This study aims to evaluate the medications used by hemorrhagic stroke patients over the past six months, assess potential DDIs, and examine their relationship with age, sex, and clinical parameters. Methods A retrospective analysis was conducted on patients diagnosed with hemorrhagic stroke both radiologically and clinically in the emergency department. Patients were categorized into three groups: hemorrhagic stroke risk interaction, non-risk interaction, and no interaction. Results Of 198 patients, 68% were male and 32% female, with a mean age of 61.93 ± 18.2 years. Chronic disease was present in 67.6% of patients; hypertension was the most common. At least one medication was used by 56.1%, and 49.5% of them had DDIs. Overall, DDIs were identified in 27.7% of all patients. Patients with hemorrhagic stroke risk interactions were significantly older (P < .001) and had more comorbidities (P < .001). Hypertension was significantly more frequent in this group (P < .001). Risk-related DDIs included 30 associated with elevated blood pressure, 12 with bleeding, and 2 with arrhythmia. Conclusion DDIs are a modifiable risk factor in hemorrhagic stroke. Medication histories should be carefully reviewed, particularly in elderly, multimorbid patients. Caution is essential in patients using antihypertensives, and polypharmacy should be minimized to reduce interaction risks.
- 1 September 2025
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (9) , 678-682
Clinical effects of potential drug-drug interactions in hemorrhagic stroke patients admitted to the emergency department
Aim Hemorrhagic stroke is a medical condition characterized by non-traumatic intracranial bleeding, leading to high mortality and morbidity, and is frequently diagnosed in emergency departments. Its prevalence varies between countries, highlighting the importance of investigating modifiable risk factors. Drug-drug interactions (DDIs) may contribute to its development. This study aims to evaluate the medications used by hemorrhagic stroke patients over the past six months, assess potential DDIs, and examine their relationship with age, sex, and clinical parameters. Methods A retrospective analysis was conducted on patients diagnosed with hemorrhagic stroke both radiologically and clinically in the emergency department. Patients were categorized into three groups: hemorrhagic stroke risk interaction, non-risk interaction, and no interaction. Results Of 198 patients, 68% were male and 32% female, with a mean age of 61.93 ± 18.2 years. Chronic disease was present in 67.6% of patients; hypertension was the most common. At least one medication was used by 56.1%, and 49.5% of them had DDIs. Overall, DDIs were identified in 27.7% of all patients. Patients with hemorrhagic stroke risk interactions were significantly older (P < .001) and had more comorbidities (P < .001). Hypertension was significantly more frequent in this group (P < .001). Risk-related DDIs included 30 associated with elevated blood pressure, 12 with bleeding, and 2 with arrhythmia. Conclusion DDIs are a modifiable risk factor in hemorrhagic stroke. Medication histories should be carefully reviewed, particularly in elderly, multimorbid patients. Caution is essential in patients using antihypertensives, and polypharmacy should be minimized to reduce interaction risks.
- 31 August 2025
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 7 (2) , 21-22
The Clinical Importance of Therapeutic Drug Monitoring in the Emergency Department and a Contemporary Perspective on Antiepileptic Drug Monitoring
Introduction Therapeutic Drug Monitoring (TDM) is the measurement of drug concentrations in blood and other body fluids, primarily performed to ensure appropriate treatment with drugs that have a narrow therapeutic range. Traditionally, TDM has been used to minimize drug toxicity. In addition, increasing interest in personalized pharmacotherapy in modern medicine has led to a broader application of TDM [1]. Situated at the intersection of clinical pharmacology, toxicology, and emergency medicine, TDM holds critical importance in patients presenting to the emergency department with symptoms such as altered mental status, cardiac arrhythmias, and seizures. Which drugs require TDM? TDM is routinely applied for drugs with a narrow therapeutic index, including antiepileptics, antidepressants, antineoplastics, antibiotics, cardioactive agents, and immunosuppressants [2]. While this approach plays an important role in disease management across various clinical settings, it is particularly vital in the diagnostic and therapeutic processes within emergency departments. Epileptic seizures and drug level monitoring in the emergency setting The number of patients presenting to the emergency department due to epileptic seizures is significant. Kamppi et al. reported that 3.3% of emergency visits between 2015 and 2018 were related to epileptic seizures and highlighted a substantial patient population within neurological emergency services [3]. In certain cases, rapid clinical decision-making is essential, requiring prompt treatment guided by rapid diagnostic tests. For this purpose, serum level measurements of older generation antiepileptic drugs—such as phenytoin, carbamazepine, and valproic acid—are commonly employed. However, newer generation antiepileptics, including lamotrigine, levetiracetam, and topiramate, exhibit more predictable pharmacokinetic properties, thus reducing the routine need for TDM [4]. Possibly for this reason, serum level monitoring for newer antiepileptic drugs is not available in every healthcare institution. Nevertheless, in special circumstances such as drug interactions, patient non-adherence, pregnancy, or impaired renal function, measuring drug concentrations of these agents may still be beneficial. Increasing the availability of such tests in healthcare settings should be a priority in the near future. Conclusion TDM remains a valuable approach, especially for optimizing therapy with drugs that have a narrow therapeutic window, and its use is expanding in the field of personalized pharmacotherapy. In emergency visits—particularly those due to epileptic seizures—monitoring of serum drug levels is crucial and is still more commonly performed for older generation antiepileptics. The accessibility of TDM for newer antiepileptic agents, as a key tool in individualized treatment strategies, deserves increased attention.
- 31 August 2025
- Published by Eurasian Journal of Toxicology, Emergency Physicians Association of Turkey in Eurasian Journal of Toxicology
- Vol. 7 (2) , 21-22
The Clinical Importance of Therapeutic Drug Monitoring in the Emergency Department and a Contemporary Perspective on Antiepileptic Drug Monitoring
Introduction Therapeutic Drug Monitoring (TDM) is the measurement of drug concentrations in blood and other body fluids, primarily performed to ensure appropriate treatment with drugs that have a narrow therapeutic range. Traditionally, TDM has been used to minimize drug toxicity. In addition, increasing interest in personalized pharmacotherapy in modern medicine has led to a broader application of TDM [1]. Situated at the intersection of clinical pharmacology, toxicology, and emergency medicine, TDM holds critical importance in patients presenting to the emergency department with symptoms such as altered mental status, cardiac arrhythmias, and seizures. Which drugs require TDM? TDM is routinely applied for drugs with a narrow therapeutic index, including antiepileptics, antidepressants, antineoplastics, antibiotics, cardioactive agents, and immunosuppressants [2]. While this approach plays an important role in disease management across various clinical settings, it is particularly vital in the diagnostic and therapeutic processes within emergency departments. Epileptic seizures and drug level monitoring in the emergency setting The number of patients presenting to the emergency department due to epileptic seizures is significant. Kamppi et al. reported that 3.3% of emergency visits between 2015 and 2018 were related to epileptic seizures and highlighted a substantial patient population within neurological emergency services [3]. In certain cases, rapid clinical decision-making is essential, requiring prompt treatment guided by rapid diagnostic tests. For this purpose, serum level measurements of older generation antiepileptic drugs—such as phenytoin, carbamazepine, and valproic acid—are commonly employed. However, newer generation antiepileptics, including lamotrigine, levetiracetam, and topiramate, exhibit more predictable pharmacokinetic properties, thus reducing the routine need for TDM [4]. Possibly for this reason, serum level monitoring for newer antiepileptic drugs is not available in every healthcare institution. Nevertheless, in special circumstances such as drug interactions, patient non-adherence, pregnancy, or impaired renal function, measuring drug concentrations of these agents may still be beneficial. Increasing the availability of such tests in healthcare settings should be a priority in the near future. Conclusion TDM remains a valuable approach, especially for optimizing therapy with drugs that have a narrow therapeutic window, and its use is expanding in the field of personalized pharmacotherapy. In emergency visits—particularly those due to epileptic seizures—monitoring of serum drug levels is crucial and is still more commonly performed for older generation antiepileptics. The accessibility of TDM for newer antiepileptic agents, as a key tool in individualized treatment strategies, deserves increased attention.
- 9 December 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (4) , 586-594
Evaluation of Lipid Profile and Statin Therapy in Patients with Atrial Fibrillation: Real-Life Data from a Tertiary Hospital
Objectives: Dyslipidemia is a modifiable risk factor of atrial fibrillation (AF). However, the majority of patients either do not receive low-density lipoprotein cholesterol (LDL-C) lowering treatment or do not meet their LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C) goal. We aimed to search whether patients with AF are being treated for dyslipidemia and/or are at target LDL-C and non-HDL-C levels if treated. Methods: This cross-sectional analysis includes 725 AF patients and was performed between 20 May 2023 and 25 November 2023, in cardiology outpatient clinics of a tertiary hospital. The demographic and clinical features of the patients were recorded. Systemic coronary risk estimation-2 (SCORE2) and old person version algorithms were used for cardiovascular disease (CVD) risk estimation. Primary prevention (PP) group involved patients with low-to-moderate, high and very high CVD risk without established atherosclerotic cardiovascular disease (ASCVD) and secondary prevention (SP) group was consisted of patients with established ASCVD. Results: The mean age of the participants was 71.98± 9.01 and 54.5% (n=368) of patients were females. 207 (30.7%) of patients were paroxysmal AF, and 468 (69.3%) were permanent AF. Prevalence of dyslipidemia and hypertriglyceridemia were 364 (53.9%) and 248 (36.7%) respectively. 9 (1.3%) and 152 (22.5%) of patients were on fibrate and statin treatment respectively. Mean LDL-C and non-HDL-C were 107.81±35.97 and 135.42±41.19 and their target attainment rates were 62 (9.2%) and 107 (15.9%), respectively. Conclusion: Control of dyslipidemia in patients with atrial fibrillation was severely poor and the most common cause was physician negligence.
- 9 December 2024
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 63 (4) , 586-594
Evaluation of Lipid Profile and Statin Therapy in Patients with Atrial Fibrillation: Real-Life Data from a Tertiary Hospital
Objectives: Dyslipidemia is a modifiable risk factor of atrial fibrillation (AF). However, the majority of patients either do not receive low-density lipoprotein cholesterol (LDL-C) lowering treatment or do not meet their LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C) goal. We aimed to search whether patients with AF are being treated for dyslipidemia and/or are at target LDL-C and non-HDL-C levels if treated. Methods: This cross-sectional analysis includes 725 AF patients and was performed between 20 May 2023 and 25 November 2023, in cardiology outpatient clinics of a tertiary hospital. The demographic and clinical features of the patients were recorded. Systemic coronary risk estimation-2 (SCORE2) and old person version algorithms were used for cardiovascular disease (CVD) risk estimation. Primary prevention (PP) group involved patients with low-to-moderate, high and very high CVD risk without established atherosclerotic cardiovascular disease (ASCVD) and secondary prevention (SP) group was consisted of patients with established ASCVD. Results: The mean age of the participants was 71.98± 9.01 and 54.5% (n=368) of patients were females. 207 (30.7%) of patients were paroxysmal AF, and 468 (69.3%) were permanent AF. Prevalence of dyslipidemia and hypertriglyceridemia were 364 (53.9%) and 248 (36.7%) respectively. 9 (1.3%) and 152 (22.5%) of patients were on fibrate and statin treatment respectively. Mean LDL-C and non-HDL-C were 107.81±35.97 and 135.42±41.19 and their target attainment rates were 62 (9.2%) and 107 (15.9%), respectively. Conclusion: Control of dyslipidemia in patients with atrial fibrillation was severely poor and the most common cause was physician negligence.
- 24 September 2024
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 15 (4) , 90-92
A GIANT BILATERAL HYDRONEPHROSIS CASE SAVED DESPITE THE PATIENT'S NEGLIGENCE
Introduction: Hydronephrosis due to nephrolithiasis is common, but giant hydronephrosis is rare in adults. Most of the cases previously identified in the literature are unilateral. In the study, we presented bilateral giant hydronephrosis. Case Report: A 40-year-old male patient stated that he had stones in both kidneys and took at least 2-3 tablets of various painkillers daily but did not come to urology check-ups due to the pandemic. The examinations detected bilateral giant hydronephrosis, and the parenchyma was severely thinned. The patient underwent bilateral ureterorenoscopic lithotripsy and inserted a double J catheter. Seven liters of fluid were drained from the right and 8 liters from the left. It was determined that the size of both kidneys of the patient, who was followed for two years, decreased by half. Conclusion: Bilateral giant hydronephrosis cases are rarely seen in the literature. With the findings in this study, we tried to show that damaged both kidneys are not life-threatening, and the COVID-19 pandemic has affected our health directly and indirectly.
- 24 September 2024
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 15 (4) , 90-92
A GIANT BILATERAL HYDRONEPHROSIS CASE SAVED DESPITE THE PATIENT'S NEGLIGENCE
Introduction: Hydronephrosis due to nephrolithiasis is common, but giant hydronephrosis is rare in adults. Most of the cases previously identified in the literature are unilateral. In the study, we presented bilateral giant hydronephrosis. Case Report: A 40-year-old male patient stated that he had stones in both kidneys and took at least 2-3 tablets of various painkillers daily but did not come to urology check-ups due to the pandemic. The examinations detected bilateral giant hydronephrosis, and the parenchyma was severely thinned. The patient underwent bilateral ureterorenoscopic lithotripsy and inserted a double J catheter. Seven liters of fluid were drained from the right and 8 liters from the left. It was determined that the size of both kidneys of the patient, who was followed for two years, decreased by half. Conclusion: Bilateral giant hydronephrosis cases are rarely seen in the literature. With the findings in this study, we tried to show that damaged both kidneys are not life-threatening, and the COVID-19 pandemic has affected our health directly and indirectly.
- Open Access
- 21 May 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
Warfarin in the Emergency Service: Drug Interactions and Clinical Considerations
Drug-drug interactions (DDIs) are common occurrences where one drug influences the blood concentrations or efficacy of another. Warfarin, known for its narrow therapeutic index, carries a heightened risk of severe drug interactions. We retrospectively analyzed the records of 211 patients using warfarin at the Emergency Health Services clinic of Kırklareli Training and Research Hospital from January 1, 2020, to December 31, 2020. Patient demographics and drug regimens were documented, and drug interaction assessments were conducted using the drugs.com database. Among the 211 patients, 17 exhibited signs of bleeding, including 5 with major bleeding and 12 with minor bleeding. Of these, 129 had INR values exceeding 2.5, while 82 had INR values below 2.5. Notably, 11 of the 17 bleeding patients had INR values above 2.5, with an average INR of 3.69. Analysis revealed that the 211 patients collectively used 111 different drugs, with an average of 3.81 drugs per prescription. Intriguingly, 33 of these drugs exhibited major, moderate, or minor inter-actions and were prescribed to 174 patients. In conclusion, cautious and selective prescription of medications is warranted for patients receiving warfarin due to the potential for significant drug interactions
- 21 May 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
Open AccessWarfarin in the Emergency Service: Drug Interactions and Clinical Considerations
Drug-drug interactions (DDIs) are common occurrences where one drug influences the blood concentrations or efficacy of another. Warfarin, known for its narrow therapeutic index, carries a heightened risk of severe drug interactions. We retrospectively analyzed the records of 211 patients using warfarin at the Emergency Health Services clinic of Kırklareli Training and Research Hospital from January 1, 2020, to December 31, 2020. Patient demographics and drug regimens were documented, and drug interaction assessments were conducted using the drugs.com database. Among the 211 patients, 17 exhibited signs of bleeding, including 5 with major bleeding and 12 with minor bleeding. Of these, 129 had INR values exceeding 2.5, while 82 had INR values below 2.5. Notably, 11 of the 17 bleeding patients had INR values above 2.5, with an average INR of 3.69. Analysis revealed that the 211 patients collectively used 111 different drugs, with an average of 3.81 drugs per prescription. Intriguingly, 33 of these drugs exhibited major, moderate, or minor inter-actions and were prescribed to 174 patients. In conclusion, cautious and selective prescription of medications is warranted for patients receiving warfarin due to the potential for significant drug interactions